// company-profile
Quince Therapeutics, Inc.
QNCXExchangeNasdaqSectorBiological Products, (No Diagnostic Substances)Inc.CAFilings65Insiders12
// api This Quince Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.
// activity-summary
Recent insider activity is bullish. Over the last 30 days, 2 insiders purchased shares. Buying was led by Senner Christopher J..
// 90-day insight
Over the last 90 days, Quince Therapeutics, Inc. insiders bought $0 across 11 transactions with no open-market sales.
- Most active insider: Roberts Brigette with 9 transactions totaling $0.
Activity skews bullish — buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 11, 2026 | Senner Christopher J. | QNCX | Award | 2,700 | $0.00 | $0K |
| Jun 11, 2026 | Lamond David | QNCX | Award | 2,700 | $0.00 | $0K |
| May 18, 2026 | Roberts Brigette | QNCX | Award | 69,350 | — | — |
| May 18, 2026 | Roberts Brigette | QNCX | Award | 362,092 | — | — |
| May 18, 2026 | Roberts Brigette | QNCX | Award | 228,855 | — | — |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Popular companies on Form4API
Browse insider trading activity for other actively-filed companies.